Image of GILEAD HIV Logo

Champions of Change: A Celebration of Black Women Changemakers in HIVDanielle Campbell, The Advocate

Text reads The Advocate, above a woman wearing a crownText reads The Advocate, above a woman wearing a crown

A conversation with Danielle Campbell, MPH, a researcher within the AIDS Clinical Trials Group (ACTG) Network and community volunteer

There’s a fire in the belly of researcher and activist Danielle Campbell that was ignited back in grade school. She remembers taking the bus from her Watts neighborhood to a very different community so that she could receive a better education. “I understood early on that I went to school where no one looked like me. Where the homes looked different, the families, stores, and neighborhood looked different,” she says of her first recognition of educational and socioeconomic disparities. It fueled her early desire to become a lawyer. “I’ve always known that fighting systems of power that create systemic oppression was something I wanted to do.”

“I’ve always known that fighting systems of power that create systemic oppression was something I wanted to do.”

Danielle Campbell

Her true mission came into focus when she witnessed disparities in healthcare. “I was 12 when I learned about death, as a result of the lack of a cancer screening,” she says of losing her grandfather. “My perspective shifted significantly. I thought, if I could occupy space, it would be a space where I could provide treatment to marginalized communities to help them stay well.” Campbell further refined that mission while attending UC Irvine, where she recalls a lecture on the HIV crisis in the Black community that took hold of her. “The professor starts talking about how HIV disproportionately impacts women of African descent, and I thought to myself, ‘Why?’ I started googling. In 2018, Black women made up less than 15% of the female population in the US, but we accounted for nearly 60% of new HIV infections in women.”

Since deciding to pursue public health, there’s been no stopping Campbell. From serving 11 years as a volunteer counselor for a mobile testing program to occupying multiple leadership roles within the American Public Health Association (APHA) she’s stayed true to her mission: “Protect people like me who don’t have anything, who came from nothing.” And she’s learned that to better protect Black women from HIV, they must be included in the research. As she explains, “What people have access to as far as prevention, treatments, or a future cure all starts with research.” That’s why she’s worked tirelessly to help bridge that gap, which seems at times to be a thankless job. But, she says, “sometimes, just sometimes, we win.” One of those times was in late 2022, when after a year of painstakingly hard work proposing a new policy statement supporting women’s inclusion in HIV-related research to the APHA, the policy statement was adopted.

Now, she’s focused on securing her next win, a doctorate from UC San Diego. And with many broadcasting the need to end the HIV epidemic, Campbell knows leveling up as she simultaneously works to level the playing field for people of color, particularly Black women, in the new HIV landscape is her best next step. “It’s a social disease. So, to help end it, you must address the social and structural factors that create systemic oppression that shows up in the bodies of people who are oppressed,” she says. Therein lies the fire for equality and liberation that she’s kept burning since childhood. “Coming from where I’m from, social justice is a part of my DNA.”

Learn more about all our Champions of Change leaders

*Viral suppression is defined as having less than 200 copies of HIV per milliliter of blood.13

Join us on social

The information on this site is intended for audiences in the United States only. The content on this site may not apply to non-U.S. audiences as regulatory control, legal requirements, and/or medical practices may vary in other countries.

WHAT WE LIVE FOR, HEALTHYSEXUAL, RADIAN, COMPASS INITIATIVE, HIV AGE POSITIVELY, TRANSCEND, ZEROING IN, the & Design, GILEAD, and the GILEAD Logo are trademarks of Gilead Sciences, Inc. All other marks referenced herein are the property of their respective owners. © 2024 Gilead Sciences, Inc. All rights reserved. US-UNBC-2002 11/24